MIR17HG and retinoblastoma: In summary, MIR17HG potentially modulates the MDM2 gene by suppressing the expression of miRNA hsa‐mir‐425‐5p, which in turn relieves p53‐mediated cell cycle inhibition by blocking the p53 signaling pathway, thus playing a role in RB development.